Stock ELOX ELOXX PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Calendar Eloxx Pharmaceuticals, Inc.

Equities

ELOX

US29014R2022

Market Closed - OTC Markets
Other stock markets
 02:26:35 2024-04-25 pm EDT 		5-day change 1st Jan Change
0.785 USD -3.09% Intraday chart for Eloxx Pharmaceuticals, Inc. -16.49% -34.58%
Apr. 11 North American Morning Briefing : Stock Futures Edge Lower Ahead of PPI Inflation Gauge DJ
Mar. 13 Almirall and Eloxx Pharmaceuticals Enter into Exclusive Agreement to License ZKN-013 for Rare Dermatological Diseases CI

Chart calendar Eloxx Pharmaceuticals, Inc.

b420d1cf0c9b2fe8d3e106c0.1yfuIYi_W1gnvFm-VZc2xg1vdg5eFXAE9wELtY0b-6I.tR6gE7z9DGx15iPfBvxvp0lXAmczbx9gn0V43aBIqNOTaYJ42_g6B02IFA~f23cea05456e22fc5071ab2adaf98eab

Upcoming events on Eloxx Pharmaceuticals, Inc.

2024-05-08 Q1 2024 Earnings Release (Projected)
2024-08-06 Q2 2024 Earnings Release (Projected)
2024-11-06 Q3 2024 Earnings Release (Projected)

Past events on Eloxx Pharmaceuticals, Inc.

2023-11-13 04:15 pm Q3 2023 Earnings Release
2023-08-14 08:30 am Q2 2023 Earnings Release
2023-06-27 11:30 am Investor Day - Key Opinion Leader
2023-06-22 12:00 pm Annual General Meeting
2023-05-15 04:30 pm Q1 2023 Earnings Release
2023-04-03 08:00 am Q4 2022 Earnings Release
2023-03-13 12:00 pm Oppenheimer Healthcare Conference
2022-12-01 Reverse Split: 1 of 40
2022-11-30 10:00 am Extraordinary Shareholders Meeting
2022-11-10 05:15 pm Q3 2022 Earnings Release
2022-09-14 04:30 pm ELX-02 in Class 1 Cystic Fibrosis Phase 2 Trial Results Call
2022-08-15 08:00 am Interim 2022 Earnings Release
2022-06-15 01:00 pm Annual General Meeting
2022-05-10 08:00 am Q1 2022 Earnings Release
2022-03-31 07:00 am FY 2021 Earnings Release
2022-01-09 H.C. Wainwright BIOCONNECT Virtual Conference
2021-11-17 08:30 am ELX-02 Phase 2 Clinical Trial Results Call
2021-11-09 08:00 am Q3 2021 Earnings Release
2021-10-12 10:00 am Business Update Call
2021-08-16 04:05 pm Interim 2021 Earnings Release

Annual results

Fiscal PeriodDecember 2018 2019 2020 2021 2022 2023
Net sales
Million USD		Released
Forecast
Spread 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
-
0,00

EBITDA
Released
Forecast
Spread 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
-
0,00

EBIT
Million USD		Released
Forecast
Spread 		-47,6
-44,6
-6.75%		-50,6
-53,1
4.73%		-33,5
-36,3
7.9%		-66,0
-65,1
-1.4%		-34,4
-35,0
1.66%
0,00

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		-47,1
-44,5
-5.64%		-50,9
-53,3
4.56%		-34,6
-37,3
7.3%		-66,7
-64,8
-3.01%		-36,1
-36,5
1.19%
0,00

Net income
Million USD		Released
Forecast
Spread 		-47,2
-44,5
-5.92%		-50,9
-53,3
4.56%		-34,6
-37,3
7.3%		-66,7
-64,8
-3.01%		-36,1
-36,5
1.19%
0,00

EPS
USD		Released
Forecast
Spread 		-58,0
-55,4
-4.72%		-53,6
-55,8
3.98%		-34,4
-37,0
7.03%		-38,0
-37,6
-1.06%		-666
-16,6
-3902.4%
-7,91

Announcement Date08/03/1906/03/2012/03/2130/03/2231/03/23-

Quarterly results

Fiscal PeriodDecember 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4
Net sales
Million USD		Released
Forecast
Spread 		0,00
0,00
- 		0,00
0,00
- 		0,00
3,50
- 		0,00
2,33
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,70
- 		0,00
0,00
- 		0,00
0,00
-
0,00

EBIT
Million USD		Released
Forecast
Spread 		-10,2
-10,5
2.46%		-11,6
-10,7
-8.54%		-11,0
-7,31
-49.86%		-10,3
-8,82
-16.67%		-7,14
-9,50
24.82%		-6,03
-6,61
8.79%		-5,48
-5,30
-3.45%		-4,14
-5,00
17.2%		-3,64
-4,00
9.08%


Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		-9,89
-10,8
8.81%		-12,1
-10,4
-15.92%		-11,6
-7,43
-56.45%		-10,6
-9,17
-15.84%		-7,51
-9,90
24.16%		-6,32
-6,75
6.44%		-6,23
-5,60
-11.25%		-4,34
-5,30
18.09%		-3,59
-4,40
18.36%


Net income
Million USD		Released
Forecast
Spread 		-9,89
-10,8
8.08%		-12,1
-10,4
-15.92%		-11,6
-7,43
-56.45%		-10,6
-9,17
-15.84%		-7,51
-9,90
24.16%		-6,32
-6,75
6.44%		-6,23
-5,60
-11.25%		-4,34
-5,30
18.09%		-3,59
-4,40
18.36%


EPS
USD		Released
Forecast
Spread 		-4,40
-5,40
18.52%		-4,00
-4,80
16.67%		-5,20
-3,70
-40.54%		-4,80
-4,13
-16.13%		-3,60
-4,40
18.18%		-3,05
-2,97
-2.69%		-2,88
-2,55
-12.94%		-1,96
-1,54
-27.27%		-1,31
-1,97
33.5%
-1,43

Announcement Date08/11/2130/03/2206/05/2212/08/2210/11/2231/03/2312/05/2311/08/2313/11/23-

Upcoming sector events for Eloxx Pharmaceuticals, Inc.

2024-04-28 HITGEN INC.: Q1 2024 Earnings Release (Projected)
2024-04-28 CASSAVA SCIENCES, INC.: Q1 2024 Earnings Release (Projected)
2024-04-29 DIZAL (JIANGSU) PHARMACEUTICAL CO., LTD.: Q4 2023 Earnings Release
2024-04-29 ARVINAS, INC.: Q1 2024 Earnings Release (Projected)
2024-04-29 MABWELL (SHANGHAI) BIOSCIENCE CO., LTD.: Q1 2024 Earnings Release
2024-04-29 WUXI APPTEC CO., LTD.: Q1 2024 Earnings Release
2024-04-30 04:05 pm EXELIXIS, INC.: Q1 2024 Earnings Release
2024-04-30 SUMMIT THERAPEUTICS INC.: Q1 2024 Earnings Release
2024-04-30 MACROGENICS, INC.: Q1 2024 Earnings Release (Projected)
2024-04-30 REGENXBIO INC.: Q1 2024 Earnings Release (Projected)
More events

Past sector events for Eloxx Pharmaceuticals, Inc.

Today INVENTISBIO CO., LIMITED: Q4 2023 Earnings Release
Today SHANGHAI MEDICILON INC.: Q1 2024 Earnings Release (Projected)
Today SHANGHAI ALLIST PHARMACEUTICALS CO., LTD.: Q1 2024 Earnings Release (Projected)
Today DIZAL (JIANGSU) PHARMACEUTICAL CO., LTD.: Q1 2024 Earnings Release (Projected)
Today SHANGHAI ALLIST PHARMACEUTICALS CO., LTD.: Q4 2023 Earnings Release
Today REMEGEN CO., LTD.: Q1 2024 Earnings Release
2024-04-25 06:30 am SAGE THERAPEUTICS, INC.: Q1 2024 Earnings Release
2024-04-24 JIANGSU YAHONG MEDITECH CO., LTD.: Q1 2024 Earnings Release (Projected)
2024-04-24 BIO-THERA SOLUTIONS, LTD.: Q1 2024 Earnings Release (Projected)
2024-04-24 PTC THERAPEUTICS, INC.: Q1 2024 Earnings Release

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. ELOX Stock
  4. Calendar Eloxx Pharmaceuticals, Inc.